"Biomarkers, Tumor" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or BODY FLUIDS. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including HORMONES; ANTIGENS; amino and NUCLEIC ACIDS; ENZYMES; POLYAMINES; and specific CELL MEMBRANE PROTEINS and LIPIDS.
| Descriptor ID |
D014408
|
| MeSH Number(s) |
D23.101.140
|
| Concept/Terms |
Biomarkers, Tumor- Biomarkers, Tumor
- Tumor Biomarkers
- Markers, Biological Tumor
- Tumor Markers, Biological
- Markers, Tumor Metabolite
- Tumor Metabolite Markers
- Metabolite Markers, Tumor
- Marker, Tumor Metabolite
- Metabolite Marker, Tumor
- Tumor Metabolite Marker
- Tumor Markers, Biologic
- Biologic Tumor Markers
- Markers, Biologic Tumor
- Marker, Biologic Tumor
- Biologic Tumor Marker
- Tumor Marker, Biologic
- Biochemical Tumor Markers
- Markers, Biochemical Tumor
- Marker, Biochemical Tumor
- Biochemical Tumor Marker
- Tumor Marker, Biochemical
- Tumor Markers, Biochemical
- Carcinogen Markers
- Markers, Carcinogen
- Markers, Neoplasm Metabolite
- Neoplasm Metabolite Markers
- Marker, Neoplasm Metabolite
- Metabolite Marker, Neoplasm
- Neoplasm Metabolite Marker
- Metabolite Markers, Neoplasm
- Biological Tumor Markers
- Biological Tumor Marker
- Tumor Marker, Biological
- Marker, Biological Tumor
Markers, Tumor- Markers, Tumor
- Tumor Markers
- Biomarkers, Cancer
- Cancer Biomarkers
|
Below are MeSH descriptors whose meaning is more general than "Biomarkers, Tumor".
Below are MeSH descriptors whose meaning is more specific than "Biomarkers, Tumor".
This graph shows the total number of publications written about "Biomarkers, Tumor" by people in this website by year, and whether "Biomarkers, Tumor" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 2 | 2 |
| 1997 | 2 | 0 | 2 |
| 1998 | 5 | 3 | 8 |
| 1999 | 6 | 2 | 8 |
| 2000 | 5 | 1 | 6 |
| 2001 | 7 | 1 | 8 |
| 2002 | 4 | 6 | 10 |
| 2003 | 10 | 13 | 23 |
| 2004 | 12 | 6 | 18 |
| 2005 | 16 | 15 | 31 |
| 2006 | 17 | 10 | 27 |
| 2007 | 18 | 11 | 29 |
| 2008 | 17 | 13 | 30 |
| 2009 | 20 | 19 | 39 |
| 2010 | 20 | 20 | 40 |
| 2011 | 14 | 26 | 40 |
| 2012 | 21 | 17 | 38 |
| 2013 | 27 | 22 | 49 |
| 2014 | 28 | 18 | 46 |
| 2015 | 36 | 23 | 59 |
| 2016 | 33 | 32 | 65 |
| 2017 | 43 | 21 | 64 |
| 2018 | 38 | 28 | 66 |
| 2019 | 34 | 38 | 72 |
| 2020 | 40 | 23 | 63 |
| 2021 | 39 | 29 | 68 |
| 2022 | 1 | 30 | 31 |
| 2023 | 3 | 13 | 16 |
| 2024 | 13 | 30 | 43 |
| 2025 | 29 | 26 | 55 |
| 2026 | 22 | 13 | 35 |
To return to the timeline,
click here.
Below are the most recent publications written about "Biomarkers, Tumor" by people in Profiles.
-
High-grade astrocytoma with piloid features: A clinical and genomic analysis of prognostic factors using a large cohort. Neuro Oncol. 2026 Oct 01; 28(10):2435-2448.
-
A Clinically Integrated Pediatric Patient-Derived Xenograft Program Enables Evaluation of Cohort and Patient-Specific Biology and Therapeutic Strategies. Cancer Res. 2026 09 15; 86(18):4663-4681.
-
Inclusion of Multi-Omic Biomarkers Improves Prediction Accuracy of Response, Relapse, and Overall Survival in Acute Myeloid Leukemia Patients Receiving High-Intensity Induction Chemotherapy. Cancer Med. 2026 Sep; 15(9):e72281.
-
Biomarker-Based Eligibility for Lung Cancer Screening: Validation of the Protein-Based INTEGRAL-Risk Model. JAMA. 2026 Jul 28; 336(4):323-333.
-
Cost-effectiveness of HES V2.0 and GALAD for hepatocellular carcinoma surveillance in patients with cirrhosis. Hepatol Commun. 2026 Aug 01; 10(8).
-
Methylation signatures distinguish non-small cell lung cancer subtypes and are associated with survival in smokers with lung squamous cell carcinoma. J Natl Cancer Inst. 2026 Jul 01; 118(7):1299-1312.
-
Glyoxalase 1 promotes glioma progression by modulating Sox2 transcriptional networks in glioma stem-like cells. Neuro Oncol. 2026 Jul 01; 28(7):1680-1693.
-
Biomarker study of pembrolizumab in patients with advanced rare cancers. Cell Rep Med. 2026 Jun 16; 7(6):102827.
-
Biallelic ARID1A Alterations : A Promising Novel Biomarker for Risk Stratification and Management in Pediatric Malignant Hepatocellular Tumors. Am J Surg Pathol. 2026 09 01; 50(9):1106-1119.
-
Understanding and Overcoming Osteosarcoma Heterogeneity. Biomolecules. 2026 Jun 15; 16(6).